TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal

Y Li, M Xue, X Deng, L Dong, L Ren, L Han, C Li, J Xue… - Cell Stem Cell, 2023 - cell.com
TET2 is recurrently mutated in acute myeloid leukemia (AML) and its deficiency promotes
leukemogenesis (driven by aggressive oncogenic mutations) and enhances leukemia stem …

[HTML][HTML] Restoration of TET2 function blocks aberrant self-renewal and leukemia progression

L Cimmino, I Dolgalev, Y Wang, A Yoshimi, GH Martin… - Cell, 2017 - cell.com
Loss-of-function mutations in TET2 occur frequently in patients with clonal hematopoiesis,
myelodysplastic syndrome (MDS), and acute myeloid leukemia (AML) and are associated …

[HTML][HTML] TET genes: new players in DNA demethylation and important determinants for stemness

F Mohr, K Döhner, C Buske, VPS Rawat - Experimental hematology, 2011 - Elsevier
Stem cells are defined as cells that have the ability to perpetuate themselves through self-
renewal and to generate functional mature cells by differentiation. During each stage …

TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition

S Bamezai, D Demir, AJ Pulikkottil, F Ciccarone… - Leukemia, 2021 - nature.com
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer
characterized by skewed epigenetic patterns, raising the possibility of therapeutically …

TET2: a cornerstone in normal and malignant hematopoiesis

H Kunimoto, H Nakajima - Cancer Science, 2021 - Wiley Online Library
Regulation of genome‐wide DNA methylation is fundamental for a variety of biological
processes such as mammalian development, stem cell function, cellular proliferation …

TET2 loss dysregulates the behavior of bone marrow mesenchymal stromal cells and accelerates Tet2−/−-driven myeloid malignancy progression

R Li, Y Zhou, Z Cao, L Liu, J Wang, Z Chen, W Xing… - Stem cell reports, 2018 - cell.com
TET2 is a methylcytosine dioxygenase that regulates cytosine hydroxymethylation. Although
there are extensive data implicating a pivotal role of TET2 in hematopoietic stem/progenitor …

MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy) methylation and gene expression to maintain a neoplastic phenotype in T-ALL

CJ Poole, A Lodh, JH Choi, J Van Riggelen - Epigenetics & chromatin, 2019 - Springer
Background While aberrant DNA methylation is a characteristic feature of tumor cells, our
knowledge of how these DNA methylation patterns are established and maintained is …

TET1 regulates gene expression and repression of endogenous retroviruses independent of DNA demethylation

P Stolz, AS Mantero, A Tvardovskiy, E Ugur… - Nucleic Acids …, 2022 - academic.oup.com
Abstract DNA methylation (5-methylcytosine (5mC)) is critical for genome stability and
transcriptional regulation in mammals. The discovery that ten-eleven translocation (TET) …

Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications

H Lopez-Bertoni, A Johnson, Y Rui, B Lal… - Signal transduction and …, 2022 - nature.com
DNA methylation is a reversible process catalyzed by the ten–eleven translocation (TET)
family of enzymes (TET1, TET2, TET3) that convert 5-methylcytosine (5mC) to 5 …

The TET2 interactors and their links to hematological malignancies

F Pan, O Weeks, FC Yang, M Xu - IUBMB life, 2015 - Wiley Online Library
Ten‐eleven translocation (TET) family proteins are dioxygenases that oxidize 5‐
methylcytosine to 5‐hydroxymethylcytosine, 5‐formylcytosine, and 5‐carboxylcytosine in …